Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-19 | Ms. Denise L. DevineIndependent Director | -4,00k | 4,08k | Vente | 1,02 | 367,21k | -1,08% |
| 2026-02-28 | Mr. Christopher E. WolfeIndependent Director | 9,50k | 0,00 | Derivative Exercise and Retained Stock | - | 9,50k | - |
| 2026-02-28 | Mr. Srdjan VukovicIndependent Director | 9,50k | 0,00 | Derivative Exercise and Retained Stock | - | 9,50k | - |
| 2026-02-28 | Mr. Ryan M. ClementCFO | 17,69k | 0,00 | Derivative Exercise and Retained Stock | - | 322,39k | 5,80% |
| 2026-02-28 | Mr. Ryan M. ClementCFO | -9,38k | 8,07k | Derivative Exercise and Sale | 0,86 | 322,39k | - |
| 2026-02-11 | Mr. Robert Clay GrantPresident | 118,90k | 105,02k | Achat | 0,88 - 0,89 | 4,44M | 2,75% |
| 2025-11-11 | Dr. Kavita K. PatelIndependent Director | 52,63k | 0,00 | Derivative Exercise and Retained Stock | - | 363,21k | 16,95% |
| 2025-11-11 | Ms. Denise L. DevineIndependent Director | 52,63k | 0,00 | Derivative Exercise and Retained Stock | - | 371,21k | 16,52% |
| 2025-11-11 | Mr. Donald Louis HawksIndependent Chairman | 52,63k | 0,00 | Derivative Exercise and Retained Stock | - | 513,21k | 11,43% |
| 2025-11-11 | Mr. Earl H. DevannyIndependent Director | 52,63k | 0,00 | Derivative Exercise and Retained Stock | - | 363,21k | 16,95% |
| 2025-11-11 | Mr. Raymond Francis WeldonIndependent Director | 52,63k | 0,00 | Derivative Exercise and Retained Stock | - | 513,21k | 11,43% |
| 2025-08-01 | Ms. Stephanie D. FisherCAO | 34,39k | 0,00 | Derivative Exercise and Retained Stock | - | 104,58k | 48,98% |
| 2025-08-01 | Ms. Stephanie D. FisherCAO | -25,27k | 43,96k | Derivative Exercise and Sale | 1,74 | 104,58k | - |
| 2025-08-01 | Mr. Joshua Brandon MatthewsPresident of SelectQuote Senior | 144,32k | 0,00 | Derivative Exercise and Retained Stock | - | 625,94k | 29,97% |
| 2025-08-01 | Mr. Ryan M. ClementCFO | 149,24k | 0,00 | Derivative Exercise and Retained Stock | - | 304,71k | 95,99% |
| 2025-08-01 | Mr. Ryan M. ClementCFO | -62,00k | 107,88k | Derivative Exercise and Sale | 1,74 | 304,71k | - |
| 2025-08-01 | Mr. William Thomas GrantCOO | 365,76k | 0,00 | Derivative Exercise and Retained Stock | - | 4,20M | 9,54% |
| 2025-08-01 | Mr. William Thomas GrantCOO | -183,02k | 318,45k | Derivative Exercise and Sale | 1,74 | 4,20M | - |
| 2025-08-01 | Mr. Robert Clay GrantPresident | 426,93k | 0,00 | Derivative Exercise and Retained Stock | - | 4,32M | 10,97% |
| 2025-08-01 | Mr. Robert Clay GrantPresident | -204,16k | 355,24k | Derivative Exercise and Sale | 1,74 | 4,32M | - |
| 2025-08-01 | Mr. Timothy Robert DankerCEO & Director | 459,31k | 0,00 | Derivative Exercise and Retained Stock | - | 2,63M | 21,12% |
| 2025-08-01 | Mr. Timothy Robert DankerCEO & Director | -199,22k | 346,63k | Derivative Exercise and Sale | 1,74 | 2,63M | - |
| 2025-08-01 | Mr. Daniel A. BoulwareGeneral Counsel & Corporate Secretary | 126,91k | 0,00 | Derivative Exercise and Retained Stock | - | 290,77k | 77,44% |
| 2025-08-01 | Mr. Daniel A. BoulwareGeneral Counsel & Corporate Secretary | -93,58k | 162,83k | Derivative Exercise and Sale | 1,74 | 290,77k | - |
| 2025-08-01 | Ms. Sarah Taylor AndersonExec. VP of Healthcare Pharmacy Services | 44,11k | 0,00 | Derivative Exercise and Retained Stock | - | 51,63k | 586,59% |
| 2025-08-01 | Ms. Sarah Taylor AndersonExec. VP of Healthcare Pharmacy Services | -18,33k | 31,89k | Derivative Exercise and Sale | 1,74 | 51,63k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.